Cargando…
Drug-induced ‘Torsade de Pointes’ in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report
BACKGROUND: Early studies have led to the repositioning of a subgroup of antimalarial agents (e.g. chloroquine and hydroxychloroquine) as antiviral treatment in coronavirus disease 2019 (COVID-19) patients. These drugs are now being prescribed based on small non-controlled studies, but larger contro...
Autores principales: | Semedo, Edimir, Kapel, Gijs F, van Opstal, Jurren, van Dessel, Pascal F H M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454487/ https://www.ncbi.nlm.nih.gov/pubmed/33089050 http://dx.doi.org/10.1093/ehjcr/ytaa218 |
Ejemplares similares
-
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019
por: Szekely, Yishay, et al.
Publicado: (2020) -
Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020) -
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021) -
A tale of 2 torsades: How to approach a patient with torsades de pointes and distinguish between classical and pseudo–torsades de pointes
por: Scheinman, Melvin, et al.
Publicado: (2022) -
Ondansetron induced torsades de pointes
por: Patel, Eshan, et al.
Publicado: (2019)